Predictions
Emergent Biosolutions Inc.
Start price
Target price
Perf. (%)
€7.26
23.03.23
23.03.23
€11.00
23.03.24
23.03.24
-79.47%
13.02.24
13.02.24
Could be worthwhile Investment >10% per year
Blueprint Medicines Corp
Start price
Target price
Perf. (%)
€64.00
30.11.23
30.11.23
-
30.11.24
30.11.24
10.94%
31.01.24
31.01.24
Sage Therapeutics Inc.
Start price
Target price
Perf. (%)
€37.80
04.04.23
04.04.23
-
04.04.24
04.04.24
-37.04%
31.01.24
31.01.24
Emergent Biosolutions Inc.
Start price
Target price
Perf. (%)
€2.02
07.01.24
07.01.24
-
07.01.25
07.01.25
-16.47%
19.01.24
19.01.24
Probably not worthwhile Investment
Bluebird Bio Inc.
Start price
Target price
Perf. (%)
€4.00
02.12.23
02.12.23
€5.00
31.10.25
31.10.25
-30.50%
10.12.23
10.12.23
Could be very worthwhile Investment >20% year
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€19.62
30.11.23
30.11.23
-
30.11.24
30.11.24
12.62%
08.12.23
08.12.23
Could be very worthwhile Investment >20% year
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€17.20
28.10.23
28.10.23
€8.00
28.10.24
28.10.24
-4.07%
11.11.23
11.11.23
Probably not worthwhile Investment
Revenue decline/stagnation expected
Lower EBIT Margin than peer group
negative Cash Flow expected
Medpace Holdings Inc
Start price
Target price
Perf. (%)
€218.90
25.10.22
25.10.22
€190.00
25.10.23
25.10.23
11.47%
26.10.23
26.10.23
Could be worthwhile Investment >10% per year
Mirati Therapeutics Inc.
Start price
Target price
Perf. (%)
€59.10
05.10.23
05.10.23
-
05.10.24
05.10.24
-8.93%
15.10.23
15.10.23
Could be worthwhile Investment >10% per year
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€19.60
30.09.23
30.09.23
€9.00
30.09.24
30.09.24
11.22%
14.10.23
14.10.23
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Teladoc Health Inc
Start price
Target price
Perf. (%)
€22.88
14.07.23
14.07.23
€26.00
14.07.24
14.07.24
-22.31%
01.10.23
01.10.23
Significant cyclical dependencies
ROE lower than 10% per year
high free float
Little known brand
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€24.00
16.09.23
16.09.23
€12.00
16.09.24
16.09.24
-13.33%
30.09.23
30.09.23
Probably not worthwhile Investment
Revenue decline/stagnation expected
Lower EBIT Margin than peer group
negative Cash Flow expected
Iovance Biotherapeutics Inc.
Start price
Target price
Perf. (%)
€4.35
14.09.23
14.09.23
-
14.09.24
14.09.24
22.42%
16.09.23
16.09.23
Could be very worthwhile Investment >20% year
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€25.20
15.09.23
15.09.23
-
15.09.24
15.09.24
-4.76%
16.09.23
16.09.23
Could be very worthwhile Investment >20% year
Nektar Therapeutics
Start price
Target price
Perf. (%)
€0.95
07.08.23
07.08.23
-
07.08.24
07.08.24
-29.26%
19.08.23
19.08.23
Could be worthwhile Investment >10% per year
Good culture
Capable Management
Few uniques
Sage Therapeutics Inc.
Start price
Target price
Perf. (%)
€15.10
07.08.23
07.08.23
-
07.08.24
07.08.24
21.19%
18.08.23
18.08.23
Capable Management
Risky Investment
No uniques
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€51.50
16.08.22
16.08.22
-
16.08.23
16.08.23
-27.77%
16.08.23
16.08.23
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€104.86
16.08.22
16.08.22
-
16.08.23
16.08.23
-6.73%
16.08.23
16.08.23